Trials / Sponsors / Midland Research Group, Inc.
Midland Research Group, Inc.
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) Human Immunodeficiency Virus | Phase 4 | 2019-09-17 |
| Completed | Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults Wit Human Immunodeficiency Virus | Phase 4 | 2018-03-01 |